Harness AI to Boldly Develop and Deliver Revolutionary Therapies for Patients with Serious Diseases.
METiS Therapeutics is a discovery technology and therapeutics company that has the potential to drive best-in-class drug assets in a wide range of therapeutic areas.
The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-driven quantum mechanics and molecular dynamics simulations to calculate active pharmaceutical ingredient (API) properties, elucidate API-target and API-excipient interactions, and predict chemical, physical and pharmacokinetic properties of small molecule and nucleic acid therapeutics in specific microenvironments. This enables efficient lead optimization, candidate selection and formulation design.
Our Mission
Build a world-class proprietary predictive AI platform to redefine drug discovery
Create a robust and targeted delivery system for small molecules, RNA and gene therapies
Provide clinical value to patients by exploring the uncharted territory of AI and the new biology
Partnering
METiS is interested on in-licensing novel assets with high therapeutic potential that could benefit from our technologies. To inquire about partnering with METiS or to collaborate on an external program, please reach out to partner@metistx.com.
We take pride in our investors
.jpeg)
In the News
January 6, 2023
September 13, 2022
May 18, 2022
